Education
About Us
Working with TipRanks
Follow Us
Iridex Corp (IRIX)
NASDAQ:IRIX
IRIX Stock Chart & Stats
$0.95
-$0.02(-1.39%)
At close: 4:00 PM EST
$0.95
-$0.02(-1.39%)
Day’s Range― - ―
52-Week Range$0.78 - $1.95
Previous CloseN/A
Volume8.51K
Average Volume (3M)66.91K
Market Cap
$17.67M
Enterprise Value$19.07M
Total Cash (Recent Filing)$6.78M
Total Debt (Recent Filing)$5.07M
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Mar 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding16,992,252
10 Day Avg. Volume69,445
30 Day Avg. Volume66,914
Financial Highlights & Ratios
PEG Ratio0.37
Price to Book (P/B)13.17
Price to Sales (P/S)0.57
P/FCF Ratio-3.78
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit1.36
Enterprise Value/Ebitda-5.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Iridex News
IRIX FAQ
What was Iridex Corp’s price range in the past 12 months?
Iridex Corp lowest stock price was $0.78 and its highest was $1.95 in the past 12 months.
What is Iridex Corp’s market cap?
Iridex Corp’s market cap is $17.67M.
When is Iridex Corp’s upcoming earnings report date?
Iridex Corp’s upcoming earnings report date is Mar 05, 2026 which is in 112 days.
How were Iridex Corp’s earnings last quarter?
Iridex Corp released its earnings results on Nov 11, 2025. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.09.
Is Iridex Corp overvalued?
According to Wall Street analysts Iridex Corp’s price is currently Overvalued.
Does Iridex Corp pay dividends?
Iridex Corp does not currently pay dividends.
What is Iridex Corp’s EPS estimate?
Iridex Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Iridex Corp have?
Iridex Corp has 16,992,252 shares outstanding.
What happened to Iridex Corp’s price movement after its last earnings report?
Iridex Corp reported an EPS of -$0.09 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20.168%.
Which hedge fund is a major shareholder of Iridex Corp?
Currently, no hedge funds are holding shares in IRIX
Company Description
Iridex Corp
Iridex Corporation (IRIX) is a leading provider of innovative medical technology solutions for the treatment of eye diseases. The company specializes in developing laser-based systems and delivery devices that are primarily used in the fields of ophthalmology and dermatology. Iridex's core products include laser systems for retinal therapies, as well as technologies for the treatment of various skin conditions, making it a pivotal player in the medical device sector focused on improving patient outcomes in vision and skin health.
IRIX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful cost-cutting measures leading to improved adjusted EBITDA and projections for positive cash flow. However, challenges such as a decrease in gross margin and market difficulties in Asia tempered the overall positive outlook.View all IRIX earnings summariesTechnical Analysis
Sintx Technologies
―
PAVmed
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Envoy Medical
―
Ownership Overview
5.74% Insiders
4.10% Mutual Funds
8.00% Other Institutional Investors
79.13% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---